{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:02:17Z","timestamp":1789686137511,"version":"4.0.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["No. LY23B070004"],"award-info":[{"award-number":["No. LY23B070004"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82374136"],"award-info":[{"award-number":["No. 82374136"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key R&D Program of Zhejiang","award":["No.2024SDXT001-7"],"award-info":[{"award-number":["No.2024SDXT001-7"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Sci Food"],"DOI":"10.1038\/s41538-026-00820-9","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:06:58Z","timestamp":1775279218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dietary silver nanoparticle supplementation induces Alzheimer-like lesions through Bifidobacterium deficiency-dominated gut microbiota dysbiosis and neuroinflammation"],"prefix":"10.1038","volume":"10","author":[{"given":"Rongshang","family":"Shou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zige","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"820_CR1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12989-022-00459-w","volume":"19","author":"R Landsiedel","year":"2022","unstructured":"Landsiedel, R. et al. Gut microbiome and plasma metabolome changes in rats after oral gavage of nanoparticles: sensitive indicators of possible adverse health effects. Part. Fibre Toxicol. 19, 21 (2022).","journal-title":"Part. Fibre Toxicol."},{"key":"820_CR2","doi-asserted-by":"crossref","first-page":"104676","DOI":"10.1016\/j.resconrec.2019.104676","volume":"156","author":"S Temizel-Sekeryan","year":"2020","unstructured":"Temizel-Sekeryan, S. & Hicks, A. L. Global environmental impacts of silver nanoparticle production methods supported by life cycle assessment. Resour. Conserv. Recycl. 156, 104676 (2020).","journal-title":"Resour. Conserv. Recycl."},{"key":"820_CR3","unstructured":"Research and Markets. Silver Nanoparticles Market Size, Share & Trends Analysis Report By Application (Electronics & Electrical, Healthcare, Food & Beverages, Textiles, Others), By Region, And Segment Forecasts, 2024\u20142030. https:\/\/www.researchandmarkets.com\/reports\/5998829\/silver-nanoparticles-market-size-share-and-trends (2024)."},{"key":"820_CR4","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.3390\/pharmaceutics13122034","volume":"13","author":"ZA Ratan","year":"2021","unstructured":"Ratan, Z. A. et al. Silver nanoparticles as potential antiviral agents. Pharmaceutics 13, 2034 (2021).","journal-title":"Pharmaceutics"},{"key":"820_CR5","first-page":"397","volume":"24","author":"SL Archer","year":"2008","unstructured":"Archer, S. L. Dilated cardiomyopathy and left bundle branch block associated with ingestion of colloidal gold and silver is reversed by British antiLewisite and vitamin E: the potential toxicity of metals used as health supplements. Can. J. Cardiol. 24, 397\u2013399 (2008).","journal-title":"Can. J. Cardiol."},{"key":"820_CR6","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1503\/cmaj.171374","volume":"190","author":"NA Bracey","year":"2018","unstructured":"Bracey, N. A., Zipursky, J. S. & Juurlink, D. N. Argyria caused by chronic ingestion of silver. CMAJ 190, E139 (2018).","journal-title":"CMAJ"},{"key":"820_CR7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/00185787231151862","volume":"58","author":"D Hu","year":"2023","unstructured":"Hu, D. & Yuen, C. Seizures following self-medication with colloidal silver: a case report. Hosp. Pharm. 58, 350\u2013352 (2023).","journal-title":"Hosp. Pharm."},{"key":"820_CR8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/1078155219832966","volume":"26","author":"Y-K Keung","year":"2020","unstructured":"Keung, Y.-K., Wang, T. & Hong-Lung Hu, E. Acute myeloid leukemia with complex cytogenetic abnormalities associated with long-term use of oral colloidal silver as nutritional supplement\u2014Case report and review of literature. J. Oncol. Pharm. Pr. 26, 212\u2013215 (2020).","journal-title":"J. Oncol. Pharm. Pr."},{"key":"820_CR9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.12659\/AJCR.915499","volume":"20","author":"N Mohan","year":"2019","unstructured":"Mohan, N., Gomez, C., Khawar, N., Narula, P. & John, M. Colloidal silver ingestion associated with leukocytoclastic vasculitis in an adolescent female. Am. J. Case Rep. 20, 730\u2013734 (2019).","journal-title":"Am. J. Case Rep."},{"key":"820_CR10","unstructured":"Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule. Fed. Regist. 64, 44653\u201344658 (1999)."},{"key":"820_CR11","volume":"16","author":"EFSA Panel on Food Additives and Nutrient Sources added to Food (EFSA ANS Panel","year":"2018","unstructured":"EFSA Panel on Food Additives and Nutrient Sources added to Food (EFSA ANS Panel) et al. Safety and bioavailability of silver hydrosol as a source of silver added for nutritional purposes to food supplements. EFSA J. 16, e05237 (2018).","journal-title":"EFSA J."},{"key":"820_CR12","first-page":"e05327","volume":"16","author":"EFSA Scientific Committee","year":"2018","unstructured":"EFSA Scientific Committee et al. Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain: Part 1, human and animal health. EFSA J. 16, e05327 (2018).","journal-title":"EFSA J."},{"key":"820_CR13","first-page":"e06790","volume":"19","author":"EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP","year":"2021","unstructured":"EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP) et al. Safety assessment of the substance silver nanoparticles for use in food contact materials. EFSA J. 19, e06790 (2021).","journal-title":"EFSA J."},{"key":"820_CR14","unstructured":"EFSA Scientific Committee et al. Guidance on risk assessment of nanomaterials to be applied in the food and feed chain: human and animal health. EFSA J. 19, e06768 (2021)."},{"key":"820_CR15","unstructured":"State Food and Drug Administration. Announcement of the State Food and Drug Administration on Regulating Matters Related to the Registration and Management of Medical Devices Containing Silver Salts (No. 225 of 2015), https:\/\/www.nmpa.gov.cn\/xxgk\/ggtg\/ylqxggtg\/ylqxqtggtg\/20151109120001276.html (accessed October 16, 2024)."},{"key":"820_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12989-021-00418-x","volume":"18","author":"R Camilla","year":"2021","unstructured":"Camilla, R. et al. Repeated oral administration of low doses of silver in mice: tissue distribution and effects on central nervous system. Part. Fibre Toxicol. 18, 23 (2021).","journal-title":"Part. Fibre Toxicol."},{"key":"820_CR17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/jat.4317","volume":"43","author":"JK Suthar","year":"2023","unstructured":"Suthar, J. K., Vaidya, A. & Ravindran, S. Toxic implications of silver nanoparticles on the central nervous system: a systematic literature review. J. Appl. Toxicol. 43, 4\u201321 (2023).","journal-title":"J. Appl. Toxicol."},{"key":"820_CR18","doi-asserted-by":"crossref","first-page":"8792","DOI":"10.1021\/acs.est.8b01393","volume":"52","author":"W Wu","year":"2018","unstructured":"Wu, W. et al. Transformation and speciation analysis of silver nanoparticles of dietary supplement in simulated human gastrointestinal tract. Environ. Sci. Technol. 52, 8792\u20138800 (2018).","journal-title":"Environ. Sci. Technol."},{"key":"820_CR19","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/01.WNL.0000120671.73335.EC","volume":"62","author":"SM Mirsattari","year":"2004","unstructured":"Mirsattari, S. M., Hammond, R. R., Sharpe, M. D., Leung, F. Y. & Young, G. B. Myoclonic status epilepticus following repeated oral ingestion of colloidal silver. Neurology 62, 1408\u20131410 (2004).","journal-title":"Neurology"},{"key":"820_CR20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.fct.2013.07.071","volume":"60","author":"R Ebabe Elle","year":"2013","unstructured":"Ebabe Elle, R. et al. Dietary exposure to silver nanoparticles in Sprague\u2013Dawley rats: effects on oxidative stress and inflammation. Food Chem. Toxicol. 60, 297\u2013301 (2013).","journal-title":"Food Chem. Toxicol."},{"key":"820_CR21","doi-asserted-by":"crossref","DOI":"10.1016\/j.marpolbul.2025.118354","volume":"219","author":"H Moghadam","year":"2025","unstructured":"Moghadam, H. et al. Toxicological effects of dietary silver nanoparticles (AgNPs) and zinc oxide nanoparticles (ZnONPs) on zebrafish (Danio rerio): a comprehensive study on mixture toxicity. Mar. Pollut. Bull. 219, 118354 (2025).","journal-title":"Mar. Pollut. Bull."},{"key":"820_CR22","doi-asserted-by":"crossref","first-page":"101982","DOI":"10.1016\/j.xcrm.2025.101982","volume":"6","author":"KJ O\u2019Riordan","year":"2025","unstructured":"O\u2019Riordan, K. J., Moloney, G. M., Keane, L., Clarke, G. & Cryan, J. F. The gut microbiota-immune-brain axis: Therapeutic implications. Cell Rep. Med. 6, 101982 (2025).","journal-title":"Cell Rep. Med."},{"key":"820_CR23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmgh.2018.04.003","volume":"6","author":"CR Martin","year":"2018","unstructured":"Martin, C. R., Osadchiy, V., Kalani, A. & Mayer, E. A. The brain-gut-microbiome Axis. Cell. Mol. Gastroenterol. Hepatol. 6, 133\u2013148 (2018).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"820_CR24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2022.113442","volume":"236","author":"E Guilloteau","year":"2022","unstructured":"Guilloteau, E. et al. Exposure to atmospheric Ag, TiO2, Ti and SiO2 engineered nanoparticles modulates gut inflammatory response and microbiota in mice. Ecotoxicol. Environ. Saf. 236, 113442 (2022).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"820_CR25","doi-asserted-by":"crossref","DOI":"10.1186\/s12989-020-00349-z","volume":"17","author":"B Lamas","year":"2020","unstructured":"Lamas, B., Martins Breyner, N. & Houdeau, E. Impacts of foodborne inorganic nanoparticles on the gut microbiota-immune axis: potential consequences for host health. Part Fibre Toxicol. 17, 19 (2020).","journal-title":"Part Fibre Toxicol."},{"key":"820_CR26","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112352","volume":"154","author":"L Perez","year":"2021","unstructured":"Perez, L. et al. Dietary nanoparticles alter the composition and function of the gut microbiota in mice at dose levels relevant for human exposure. Food Chem. Toxicol. 154, 112352 (2021).","journal-title":"Food Chem. Toxicol."},{"key":"820_CR27","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.scitotenv.2017.11.195","volume":"619\u2013620","author":"KR Rogers","year":"2018","unstructured":"Rogers, K. R. et al. Characterization of engineered nanoparticles in commercially available spray disinfectant products advertised to contain colloidal silver. Sci. Total Environ. 619\u2013620, 1375\u20131384 (2018).","journal-title":"Sci. Total Environ."},{"key":"820_CR28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.colsurfb.2017.09.042","volume":"160","author":"M O\u0107wieja","year":"2017","unstructured":"O\u0107wieja, M., Barbasz, A., Walas, S., Roman, M. & Paluszkiewicz, C. Physicochemical properties and cytotoxicity of cysteine-functionalized silver nanoparticles. Colloids Surf. B Biointerfaces 160, 429\u2013437 (2017).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"820_CR29","doi-asserted-by":"publisher","unstructured":"Bergin, I. L. & Witzmann, F. A. Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. Int. J. Biomed. Nanosci. Nanotechnol. 3, https:\/\/doi.org\/10.1504\/IJBNN.2013.054515 (2013).","DOI":"10.1504\/IJBNN.2013.054515"},{"key":"820_CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 7, 27\u201331 (2016).","journal-title":"J. Basic Clin. Pharm."},{"key":"820_CR31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02916928","volume":"6","author":"RS Gibson","year":"1984","unstructured":"Gibson, R. S. & Scythes, C. A. Chromium, selenium, and other trace element intakes of a selected sample of Canadian premenopausal women. Biol. Trace Elem. Res. 6, 105\u2013116 (1984).","journal-title":"Biol. Trace Elem. Res."},{"key":"820_CR32","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1039\/c3em00226h","volume":"15","author":"CM Whiteley","year":"2013","unstructured":"Whiteley, C. M., Dalla Valle, M., Jones, K. C. & Sweetman, A. J. Challenges in assessing release, exposure and fate of silver nanoparticles within the UK environment. Environ. Sci. Process Impacts 15, 2050\u20132058 (2013).","journal-title":"Environ. Sci. Process Impacts"},{"key":"820_CR33","doi-asserted-by":"crossref","unstructured":"Shahare, B., Yashpal, M. & Gajendra. Toxic effects of repeated oral exposure of silver nanoparticles on small intestine mucosa of mice. Toxicol. Mech. Methods https:\/\/www.tandfonline.com\/doi\/abs\/10.3109\/15376516.2013.764950 (2013).","DOI":"10.3109\/15376516.2013.764950"},{"key":"820_CR34","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1134\/S1063774516060031","volume":"61","author":"AA Antsiferova","year":"2016","unstructured":"Antsiferova, A. A., Buzulukov, Y.uP., Kashkarov, P. K. & Kovalchuk, M. V. Experimental and theoretical study of the transport of silver nanoparticles at their prolonged administration into a mammal organism. Crystallogr. Rep. 61, 1020\u20131026 (2016).","journal-title":"Crystallogr. Rep."},{"key":"820_CR35","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.1021\/nn302649p","volume":"6","author":"M van der Zande","year":"2012","unstructured":"van der Zande, M. et al. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 6, 7427\u20137442 (2012).","journal-title":"ACS Nano"},{"key":"820_CR36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature17312","volume":"531","author":"P Shrestha","year":"2016","unstructured":"Shrestha, P. & Klann, E. Alzheimer\u2019s disease: lost memories found. Nature 531, 450\u2013451 (2016).","journal-title":"Nature"},{"key":"820_CR37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fnagi.2019.00233","volume":"11","author":"A-L Hemonnot","year":"2019","unstructured":"Hemonnot, A.-L., Hua, J., Ulmann, L. & Hirbec, H. Microglia in Alzheimer disease: well-known targets and new opportunities. Front. Aging Neurosci. 11, 233 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"820_CR38","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus, H. & Heneka, M. T. Microglia in Alzheimer\u2019s disease. J. Clin. Investig. 127, 3240\u20133249 (2017).","journal-title":"J. Clin. Investig."},{"key":"820_CR39","volume":"9","author":"J Zhao","year":"2019","unstructured":"Zhao, J. et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci. Rep. 9, 5790 (2019).","journal-title":"Sci. Rep."},{"key":"820_CR40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jns.2011.03.023","volume":"305","author":"J Choi","year":"2011","unstructured":"Choi, J., Lee, H.-W. & Suk, K. Increased plasma levels of lipocalin 2 in mild cognitive impairment. J. Neurol. Sci. 305, 28\u201333 (2011).","journal-title":"J. Neurol. Sci."},{"key":"820_CR41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jnr.22779","volume":"90","author":"S Lee","year":"2012","unstructured":"Lee, S., Lee, W.-H., Lee, M.-S., Mori, K. & Suk, K. Regulation by lipocalin-2 of neuronal cell death, migration, and morphology. J. Neurosci. Res. 90, 540\u2013550 (2012).","journal-title":"J. Neurosci. Res."},{"key":"820_CR42","first-page":"319","volume":"72","author":"M Lodeiro","year":"2017","unstructured":"Lodeiro, M. et al. Aggregation of the Inflammatory S100A8 Precedes A\u03b2 Plaque Formation in Transgenic APP Mice: Positive Feedback for S100A8 and A\u03b2 Productions. J. Gerontol A Biol. Sci. Med Sci. 72, 319\u2013328 (2017).","journal-title":"J. Gerontol A Biol. Sci. Med Sci."},{"key":"820_CR43","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nri1106","volume":"3","author":"M Colonna","year":"2003","unstructured":"Colonna, M. TREMs in the immune system and beyond. Nat. Rev. Immunol. 3, 445\u2013453 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"820_CR44","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/biom10091283","volume":"10","author":"TTT Nguyen","year":"2020","unstructured":"Nguyen, T. T. T. et al. Tryptophanyl-tRNA synthetase 1 signals activate TREM-1 via TLR2 and TLR4. Biomolecules 10, 1283 (2020).","journal-title":"Biomolecules"},{"key":"820_CR45","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3389\/fimmu.2020.00724","volume":"11","author":"J Yang","year":"2020","unstructured":"Yang, J., Wise, L. & Fukuchi, K. TLR4 cross-talk with NLRP3 inflammasome and complement signaling pathways in Alzheimer\u2019s disease. Front. Immunol. 11, 724 (2020).","journal-title":"Front. Immunol."},{"key":"820_CR46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/jpet.109.154724","volume":"331","author":"H Mizoguchi","year":"2009","unstructured":"Mizoguchi, H. et al. Matrix metalloprotease-9 inhibition improves amyloid beta-mediated cognitive impairment and neurotoxicity in mice. J. Pharm. Exp. Ther. 331, 14\u201322 (2009).","journal-title":"J. Pharm. Exp. Ther."},{"key":"820_CR47","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-41603-0","volume":"14","author":"BF Vahsen","year":"2023","unstructured":"Vahsen, B. F. et al. C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9. Nat. Commun. 14, 5898 (2023).","journal-title":"Nat. Commun."},{"key":"820_CR48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JAD-200146","volume":"76","author":"M Hernandes-Alejandro","year":"2020","unstructured":"Hernandes-Alejandro, M. et al. Analysis of the relationship between metalloprotease-9 and Tau protein in Alzheimer\u2019s disease. J. Alzheimer\u2019s. Dis. 76, 553\u2013569 (2020).","journal-title":"J. Alzheimer\u2019s. Dis."},{"key":"820_CR49","doi-asserted-by":"crossref","DOI":"10.1186\/s12868-021-00643-2","volume":"22","author":"C Ringland","year":"2021","unstructured":"Ringland, C. et al. MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer\u2019s disease. BMC Neurosci. 22, 39 (2021).","journal-title":"BMC Neurosci."},{"key":"820_CR50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.expneurol.2017.12.016","volume":"302","author":"X-F Li","year":"2018","unstructured":"Li, X.-F. et al. Ulinastatin protects brain against cerebral ischemia\/reperfusion injury through inhibiting MMP-9 and alleviating loss of ZO-1 and occludin proteins in mice. Exp. Neurol. 302, 68\u201374 (2018).","journal-title":"Exp. Neurol."},{"key":"820_CR51","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00004647-199909000-00010","volume":"19","author":"Y Gasche","year":"1999","unstructured":"Gasche, Y. et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J. Cereb. Blood Flow. Metab. 19, 1020\u20131028 (1999).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"820_CR52","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1126\/science.abi6087","volume":"374","author":"G Agirman","year":"2021","unstructured":"Agirman, G., Yu, K. B. & Hsiao, E. Y. Signaling inflammation across the gut-brain axis. Science 374, 1087\u20131092 (2021).","journal-title":"Science"},{"key":"820_CR53","volume":"13","author":"S van den Brule","year":"2016","unstructured":"van den Brule, S. et al. Dietary silver nanoparticles can disturb the gut microbiota in mice. Part. Fibre Toxicol. 13, 38 (2016).","journal-title":"Part. Fibre Toxicol."},{"key":"820_CR54","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt, N. M. et al. Gut microbiome alterations in Alzheimer\u2019s disease. Sci. Rep. 7, 13537 (2017).","journal-title":"Sci. Rep."},{"key":"820_CR55","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.envpol.2018.11.019","volume":"245","author":"C Catt\u00f2","year":"2019","unstructured":"Catt\u00f2, C. et al. Impacts of dietary silver nanoparticles and probiotic administration on the microbiota of an in-vitro gut model. Environ. Pollut. 245, 754\u2013763 (2019).","journal-title":"Environ. Pollut."},{"key":"820_CR56","volume":"2","author":"A Ueda","year":"2021","unstructured":"Ueda, A. et al. Identification of Faecalibacterium prausnitzii strains for gut microbiome-based intervention in Alzheimer\u2019s-type dementia. Cell Rep. Med. 2, 100398 (2021).","journal-title":"Cell Rep. Med."},{"key":"820_CR57","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1111\/ene.15961","volume":"30","author":"G Chen","year":"2023","unstructured":"Chen, G., Zhou, X., Zhu, Y., Shi, W. & Kong, L. Gut microbiome characteristics in subjective cognitive decline, mild cognitive impairment and Alzheimer\u2019s disease: a systematic review and meta-analysis. Eur. J. Neurol. 30, 3568\u20133580 (2023).","journal-title":"Eur. J. Neurol."},{"key":"820_CR58","volume":"183","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Dysregulation of Ruminococcaceae and Megamonas could be predictive markers for rapid progression of mild cognitive impairment. Micro. Pathog. 183, 106272 (2023).","journal-title":"Micro. Pathog."},{"key":"820_CR59","volume":"12","author":"BJH Verhaar","year":"2021","unstructured":"Verhaar, B. J. H. et al. Gut microbiota composition is related to AD pathology. Front. Immunol. 12, 794519 (2021).","journal-title":"Front. Immunol."},{"key":"820_CR60","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/pr.2014.156","volume":"77","author":"MA Underwood","year":"2015","unstructured":"Underwood, M. A., German, J. B., Lebrilla, C. B. & Mills, D. A. Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut. Pediatr. Res. 77, 229\u2013235 (2015).","journal-title":"Pediatr. Res."},{"key":"820_CR61","volume":"7","author":"Y Kobayashi","year":"2017","unstructured":"Kobayashi, Y. et al. Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer\u2019s disease. Sci. Rep. 7, 13510 (2017).","journal-title":"Sci. Rep."},{"key":"820_CR62","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2672.2012.05344.x","volume":"113","author":"E Barrett","year":"2012","unstructured":"Barrett, E., Ross, R. P., O\u2019Toole, P. W., Fitzgerald, G. F. & Stanton, C. \u03b3-Aminobutyric acid production by culturable bacteria from the human intestine. J. Appl. Microbiol. 113, 411\u2013417 (2012).","journal-title":"J. Appl. Microbiol."},{"key":"820_CR63","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh, A., Vadder, F. D., Kovatcheva-Datchary, P. & B\u00e4ckhed, F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332\u20131345 (2016).","journal-title":"Cell"},{"key":"820_CR64","first-page":"322","volume":"17","author":"V Osadchiy","year":"2018","unstructured":"Osadchiy, V., Martin, C. R. & Mayer, E. A. The gut\u2013brain axis and the microbiome: mechanisms and clinical implications. Clinical gastroenterology and hepatology: the official clinical practice. J. Am. Gastroenterol. Assoc. 17, 322 (2018).","journal-title":"J. Am. Gastroenterol. Assoc."},{"key":"820_CR65","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","volume":"510","author":"M Maceyka","year":"2014","unstructured":"Maceyka, M. & Spiegel, S. Sphingolipid metabolites in inflammatory disease. Nature 510, 58\u201367 (2014).","journal-title":"Nature"},{"key":"820_CR66","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbalip.2010.05.003","volume":"1801","author":"NJ Haughey","year":"2010","unstructured":"Haughey, N. J., Bandaru, V. V., Bai, M. & Mattson, M. P. Roles for dysfunctional sphingolipid metabolism in Alzheimer\u2019s disease neuropathogenesis. Biochim. Biophys. Acta 1801, 878 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"820_CR67","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","volume":"31","author":"X He","year":"2008","unstructured":"He, X., Huang, Y., Li, B., Gong, C.-X. & Schuchman, E. H. Deregulation of sphingolipid metabolism in Alzheimer\u2019s disease. Neurobiol. aging 31, 398 (2008).","journal-title":"Neurobiol. aging"},{"key":"820_CR68","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler, R. G. et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc. Natl. Acad. Sci. USA 101, 2070 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"820_CR69","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1471-4159.2002.00997.x","volume":"82","author":"X Han","year":"2002","unstructured":"Han, X. et al. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer\u2019s disease: potential role in disease pathogenesis. J. Neurochem 82, 809\u2013818 (2002).","journal-title":"J. Neurochem"},{"key":"820_CR70","doi-asserted-by":"crossref","first-page":"1001422","DOI":"10.3389\/fphar.2022.1001422","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang, H., Hui, X., Wang, Y., Wang, Y. & Lu, X. Angong Niuhuang Pill ameliorates cerebral ischemia\/reperfusion injury in mice partly by restoring gut microbiota dysbiosis. Front. Pharm. 13, 1001422 (2022).","journal-title":"Front. Pharm."},{"key":"820_CR71","doi-asserted-by":"crossref","first-page":"5472792","DOI":"10.1155\/2017\/5472792","volume":"2017","author":"JWD Griffin","year":"2017","unstructured":"Griffin, J. W. D. & Bradshaw, P. C. Amino acid catabolism in Alzheimer\u2019s disease brain: friend or foe?. Oxid. Med. Cell. Longev. 2017, 5472792 (2017).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"820_CR72","doi-asserted-by":"crossref","first-page":"e63644","DOI":"10.1371\/journal.pone.0063644","volume":"8","author":"E Trushina","year":"2013","unstructured":"Trushina, E., Dutta, T., Persson, X.-M. T., Mielke, M. M. & Petersen, R. C. Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer\u2019s disease using metabolomics. PLoS ONE 8, e63644 (2013).","journal-title":"PLoS ONE"},{"key":"820_CR73","doi-asserted-by":"crossref","unstructured":"Tang, Z. et al. Urinary metabolomics reveals alterations of aromatic amino acid metabolism of Alzheimer\u2019s disease in the transgenic CRND8 mice. Curr. Alzheimer Res. 13, 764\u2013776 (2016).","DOI":"10.2174\/1567205013666160129095340"},{"key":"820_CR74","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3390\/ijms22031273","volume":"22","author":"RA Bekdash","year":"2021","unstructured":"Bekdash, R. A. The cholinergic system, the adrenergic system and the neuropathology of Alzheimer\u2019s disease. Int. J. Mol. Sci. 22, 1273 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"820_CR75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4137\/IJTR.S2129","volume":"2","author":"DM Richard","year":"2009","unstructured":"Richard, D. M. et al. L-Tryptophan: basic metabolic functions, behavioral research and therapeutic indications. Int J. Tryptophan Res. 2, 45\u201360 (2009).","journal-title":"Int J. Tryptophan Res."},{"key":"820_CR76","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105314","volume":"164","author":"T Doifode","year":"2021","unstructured":"Doifode, T. et al. The impact of the microbiota-gut-brain axis on Alzheimer\u2019s disease pathophysiology. Pharm. Res. 164, 105314 (2021).","journal-title":"Pharm. Res."},{"key":"820_CR77","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1210\/me.2011-0028","volume":"25","author":"Y Cheng","year":"2011","unstructured":"Cheng, Y. et al. Leucine Deprivation Stimulates Fat Loss via Increasing CRH Expression in the Hypothalamus and Activating The Sympathetic Nervous System. Mol. Endocrinol. 25, 1624\u20131635 (2011).","journal-title":"Mol. Endocrinol."},{"key":"820_CR78","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s40520-022-02120-0","volume":"34","author":"Y Xiong","year":"2022","unstructured":"Xiong, Y. et al. The associations of serum valine with mild cognitive impairment and Alzheimer\u2019s disease. Aging Clin. Exp. Res. 34, 1807\u20131817 (2022).","journal-title":"Aging Clin. Exp. Res."},{"key":"820_CR79","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.14336\/AD.2020.0908","volume":"12","author":"S Muraoka","year":"2021","unstructured":"Muraoka, S. et al. Proteomic profiling of extracellular vesicles separated from plasma of former National Football League players at risk for chronic traumatic encephalopathy. Aging Dis. 12, 1363\u20131375 (2021).","journal-title":"Aging Dis."},{"key":"820_CR80","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3233\/JAD-210461","volume":"83","author":"P Liu","year":"2021","unstructured":"Liu, P. et al. Phenylalanine metabolism is dysregulated in human hippocampus with alzheimer\u2019s disease related pathological changes. J. Alzheimers Dis. 83, 609\u2013622 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"820_CR81","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.plefa.2006.03.002","volume":"74","author":"JKA Hampel","year":"2006","unstructured":"Hampel, J. K. A. et al. Differential modulation of cell cycle, apoptosis and PPARgamma2 gene expression by PPARgamma agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells. Prostaglandins Leukot. Ess. Fat. Acids 74, 283\u2013293 (2006).","journal-title":"Prostaglandins Leukot. Ess. Fat. Acids"},{"key":"820_CR82","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2017.04.014","volume":"56","author":"L Shi","year":"2017","unstructured":"Shi, L. et al. Early interleukin-6 enhances hepatic ketogenesis in APPSWE\/PSEN1dE9 mice via 3-hydroxy-3-methylglutary-CoA synthase 2 signaling activation by p38\/nuclear factor \u03baB p65. Neurobiol. Aging 56, 115\u2013126 (2017).","journal-title":"Neurobiol. Aging"},{"key":"820_CR83","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10048-007-0087-z","volume":"8","author":"MA Wollmer","year":"2007","unstructured":"Wollmer, M. A. et al. Association study of cholesterol-related genes in Alzheimer\u2019s disease. Neurogenetics 8, 179\u2013188 (2007).","journal-title":"Neurogenetics"},{"key":"820_CR84","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-2011-110074","volume":"26","author":"M Serpente","year":"2011","unstructured":"Serpente, M. et al. Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer\u2019s disease: genetics and expression analysis. J. Alzheimers Dis. 26, 787\u2013793 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"820_CR85","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.3390\/nu14122543","volume":"14","author":"M Abdelhamid","year":"2022","unstructured":"Abdelhamid, M., Zhou, C., Jung, C.-G. & Michikawa, M. Probiotic Bifidobacterium breve MCC1274 mitigates Alzheimer\u2019s disease-related pathologies in wild-type mice. Nutrients 14, 2543 (2022).","journal-title":"Nutrients"},{"key":"820_CR86","doi-asserted-by":"crossref","first-page":"709091","DOI":"10.3389\/fnagi.2021.709091","volume":"13","author":"H Kim","year":"2021","unstructured":"Kim, H. et al. Administration of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI improves cognitive and memory function in the mouse model of Alzheimeras disease. Front. Aging Neurosci. 13, 709091 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"820_CR87","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.1021\/acsnano.0c07323","volume":"15","author":"X Lu","year":"2021","unstructured":"Lu, X., Li, J., Lou, H., Cao, Z. & Fan, X. Genome-wide DNA methylation alterations and potential risk induced by subacute and subchronic exposure to food-grade nanosilica in mice. ACS Nano 15, 8225\u20138243 (2021).","journal-title":"ACS Nano"},{"key":"820_CR88","doi-asserted-by":"crossref","unstructured":"Authority (EFSA), E. F. S Existing approaches incorporating replacement, reduction and refinement of animal testing: applicability in food and feed risk assessment. EFSA J. 7, 1052 (2009).","DOI":"10.2903\/j.efsa.2009.1052"},{"key":"820_CR89","volume":"13","author":"J Shang","year":"2025","unstructured":"Shang, J. et al. Oral exposure to food-grade nanoparticles poses a risk of Alzheimer\u2019s disease-like symptoms by triggering autophagy defects in neurons. Adv. Sci. 13, e08096 (2025).","journal-title":"Adv. Sci."},{"key":"820_CR90","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2022.128459","volume":"430","author":"B Liang","year":"2022","unstructured":"Liang, B. et al. Brain single-nucleus transcriptomics highlights that polystyrene nanoplastics potentially induce Parkinson\u2019s disease-like neurodegeneration by causing energy metabolism disorders in mice. J. Hazard. Mater. 430, 128459 (2022).","journal-title":"J. Hazard. Mater."},{"key":"820_CR91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","volume":"31","author":"A Ennaceur","year":"1988","unstructured":"Ennaceur, A. & Delacour, J. A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav. Brain Res. 31, 47\u201359 (1988).","journal-title":"Behav. Brain Res."}],"container-title":["npj Science of Food"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41538-026-00820-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41538-026-00820-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41538-026-00820-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:45:05Z","timestamp":1780389905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41538-026-00820-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1038\/s41538-026-00820-9","relation":{},"ISSN":["2396-8370"],"issn-type":[{"value":"2396-8370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}